Indivior: U.S. court rules against generic rival’s appeal
(Reuters) – Indivior Plc notched a legal victory on Tuesday after a U.S. court reaffirmed that a generic rival could not re-launch cheaper versions of the British drugmaker’s best-selling opioid addiction treatment...
Read More